-
Mashup Score: 9Non–HDL-C Levels From Childhood to Adulthood and CVD Events - 13 day(s) ago
This study of individual participant data from 6 pooled cohorts assesses whether resolution of elevated childhood non–high-density lipoprotein cholesterol (non–HDL-C) by adulthood is associated with reduced risk of clinical cardiovascular disease (CVD) events.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 24Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events - 6 month(s) ago
This cohort study assesses the extent of coexistence between underlying pathology in patients with transient ischemic attack and minor ischemic stroke, their 5-year risk of major vascular events, and factors associated with risk with the benefit of the more recently adopted ASCOD classification…
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet-
Underlying Causes of TIA and Minor Ischemic Stroke and Risk of #MACE https://t.co/T3sstbec5U
-
-
Mashup Score: 24Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events - 6 month(s) ago
This cohort study assesses the extent of coexistence between underlying pathology in patients with transient ischemic attack and minor ischemic stroke, their 5-year risk of major vascular events, and factors associated with risk with the benefit of the more recently adopted ASCOD classification…
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet-
Underlying Causes of TIA and Minor Ischemic Stroke and Risk of #MACE https://t.co/T3sstbec5U
-
-
Mashup Score: 7QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction: - 7 month(s) ago
Abstract Background Complete revascularization using either angiography-guided or fractional flow reserve (FFR)-guided strategy can improve clinical outcomes in patients with acute myocardial infar…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Insights from a #JACCINT analysis of FRAME-AMI trial: #Angiography-guided #PCI led to an unnecessary 30% PCI in non–infarct-related artery with QFR >0.80! This was also linked to increased #MACE rates! https://t.co/TmfA09kUtm #cvAMI #CardioTwitter #ACCFIT https://t.co/Ev4KGqgdkg
-
-
Mashup Score: 5Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer: - 7 month(s) ago
Abstract Background Radiotherapy may cause grade ≥3 cardiac events, necessitating a better understanding of risk factors. The potential predictive role of imaging biomarkers with radiotherapy doses…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
#ASTRO23 #JACCCardioOnc SimPub: #MACE occurs in >20% of those undergoing RT in a median time of <2 yrs. In this article, @DoctorNoMD, et al exhibit the use of coronary artery dosimetry & imaging biomarkers to help predict MACE risk & inform personalized RT https://t.co/Sm4MQN5LT5 https://t.co/eYeMxDAuvf
-
-
Mashup Score: 20
Available online 3 June 2023, 101045 Author links open overlay panel Rohit Vyas MD, Mitra Patel MD, George V. Moukarbel MD, Rajesh Gupta
Source: www.sciencedirect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
📑. #IVUS-guided #PCI is associated w significant reduction in #MACE, cardiac death, target lesion revascularization, & stent thrombosis #CardioTwitter @rohitvyas90 @Mitra_Patel ➡️ https://t.co/lCsDnSstIs https://t.co/OiptEmG2k0
-
-
Mashup Score: 0Dr. Kohli on the SELECT Trial: Semaglutide Reduces MACE in Obese Patients With Heart Disease - 8 month(s) ago
Home > Payal Kohli > Dr. Kohli on the SELECT Trial: Semaglutide Reduces MACE in Obese Patients With Heart Disease Novo Nordisk recently announced the headline results from the SELECT cardiovascular outcomes trial, which showed that semaglutide, a GLP-1 receptor agonist, reduces major adverse cardiovascular events in overweight or obese adults with cardiovascular disease. DocWire News Medical Lead Dr. Payal Kohli talked about this landmark study and the impact of the findings on the cardiovascular community.
Source: www.docwirenews.comCategories: Expert Picks, Latest HeadlinesTweet-
@payalkohlimd discusses the SELECT trial, which demonstrated that #semaglutide reduces #MACE in overweight or obese adults with cardiovascular disease.https://t.co/IGB2vqMWnt #CVD #heartdisease #obesity https://t.co/SgIgm6mR99
-
-
Mashup Score: 2
Objectives Cardiovascular event (CVE) risk in rheumatoid arthritis (RA) was increased by glucocorticoids (GC) use. Whether there is a threshold dose and duration of GC use beyond which will increase CVE rate remains controversial. We studied the time-varying effect of GC and its dose on the risk of incident major adverse cardiovascular events (MACE) in patients with RA. Methods Patients with RA without MACE at baseline were recruited from a Hong Kong citywide database from 2006 to 2015 and followed till 2018. The primary outcome was the first occurrence of an MACE. Cox regression and inverse probability treatment weighting analyses with time-varying covariates were used to evaluate the association of GC and MACE, adjusting for demographics, traditional CV risk factors, inflammatory markers and the usage of antirheumatic drugs. Results Among 12 233 RA patients with 105 826 patient-years of follow-up and a mean follow-up duration of 8.7 years, 860 (7.0%) developed MACE. In the time-varyi
Source: ard.bmj.comCategories: Latest Headlines, RheumatologyTweet-
#RA pat. wo prior MACE recruited from Hong Kong database from 2006-2015, followed to2018: After controlling for confounding factors use of GC was associated with up to 2fold increased risk of incident #MACE long-term 💔 <5 mg dx no increase CV risk. https://t.co/SjbpjF9tkp https://t.co/RiyIhlh7Rc
-
-
Mashup Score: 6Masters athlete screening study (MASS): incidence of cardiovascular disease and major adverse cardiac events and efficacy of screening over five years - 9 month(s) ago
AbstractBackground. The efficacy of cardiovascular screening in Masters athletes (MAs) (≥35 y), and whether screening decreases their risk of major adverse card
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
🫀#master #athletes screening: During 1 year: 💚11.4% #CVD diagnoses 💚the most common: #CAD During FU 💚89 #CVD diagnoses 💚the most common:#arrhythmias 💚10 #MACE despite yearly screening Read more https://t.co/pHDjUtBjus & don't miss the Editorial https://t.co/NUR2RWtzi7 #EJPC https://t.co/dfqonI7AQx
-
-
Mashup Score: 2P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events - 10 month(s) ago
Aspirin is the only antiplatelet agent with a Class I recommendation for long-term prevention of cardiovascular events in patients with coronary arter…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
#P2Y12i or Aspirin Monotherapy for Secondary Prevention of #MACE . I performed several polls and the majority still voted for #Aspirin. Time to change the practice? https://t.co/PrAUs6KvnP
-
Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood #MACE “it’s the cholesterol stupid!”. https://t.co/KnSRf6T6t0